Medicx Fund Regulatory News (MXF)

For immediate release 7 November 2011

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Transfer of shares held by Director

The Board of MedicX Fund announces that it was notified on 4 November 2011 that Mr Christopher Bennett, the Audit Committee chairman, has transferred his shareholding in the Company of 7,251 shares to a separate pension trust of which he is a beneficiary with effect from 2 November 2011.

Mr Bennett's beneficial interest in the Company's shares remains unchanged as follows:

The shares referred to above are ordinary shares of no par value, and the total number of shares in issue is 192,604,010 with each share carrying one voting right. No shares are held in treasury.

End

For further information please contact:

MedicX Group +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited   +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith

Buchanan Communications +44 (0) 20 7466 5000

Charles Ryland/Suzanne Brocks

MedicX Fund Limited +44 (0) 1481 723 450

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 63 properties.

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.

 The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website).